Racial disparities seen in functional disability of breast cancer

This article originally appeared here.
Racial Disparities in Functional Disability of Breast Cancer
Racial Disparities in Functional Disability of Breast Cancer

(HealthDay News) -- Older women with newly diagnosed non-metastatic breast cancer frequently have functional disability, with African-American (AA) women disproportionately affected, according to a study published online Sept. 23 in Cancer.

In an effort to assess racial differences in functional disability, Cynthia Owusu, M.D., of the Case Western Reserve University in Cleveland, and colleagues conducted a cross-sectional study involving 190 women (32 percent AA) with newly diagnosed stage I through stage III breast cancer (mean age at diagnosis, 75.0 years).

The researchers found that 39 percent of participants exhibited functional disability. Participants with functional disability were significantly more likely to be AA than non-Hispanic white, after adjustment for age (odds ratio, 4.19). A higher prevalence of lower income and education among AAs explained 59 percent of the racial difference in functional disability. After accounting for socioeconomic factors, the higher prevalence of chronic medical conditions and obesity among AAs explained 40 percent of the black-white difference in functional disability.

"Given that functional disability has enormous public health consequences, including increased health care use and costs, and increased mortality, and given the importance of functional status in cancer treatment decision-making and treatment tolerance, interventions to improve functional status, particularly among older AAs with newly diagnosed stage I through III breast cancer, are warranted," the authors write.

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs